ABSTRACT Twenty one patients with tracheal tumours (10 primary and 11 secondary) have been treated with the neodymium YAG laser under general anaesthesia. Fourteen of these patients presented with impending asphyxia and in 11 cases this was dramatically relieved with emergency laser treatment. The improvements in peak expiratory flow (PEF) ranged from 26% to 512%. The three patients who did not respond were immediately given other treatments but died in hospital. The remaining seven patients were not in severe respiratory distress and were treated electively; all were thought to have benefited from their treatment, the mean increase in PEF being 36%. The improvement obtained in the 11 patients who responded to emergency laser treatment provided time in which to assess the disease carefully and plan the most appropriate longer term management with surgery, radiotherapy, tracheal stenting, or repeat laser treatment. The patients who were treated electively have either not required further treatment or have been managed with repeat laser treatments alone. Laser treatment provides an excellent method of resuscitating patients with life threatening tracheal obstruction and enables subsequent management to be carefully planned. In some cases this longer term management should be with further laser treatment alone.
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PATIENTS
From February 1984 to February 1986, 21 patients with tracheal tumours were referred to us for laser treatment. Tissue for histological examination was obtained from all patients and the tumour types are shown in table 1. For the 10 patients (seven of them men) with primary tumours the average age was 63 years. Details of the patient with a primary malignant mixed tumour have already been reported.7
For the 11 patients (five of them men) with secondary tumours the average age was 65 years. The site of the primary tumour was the lung in eight patients, the (4) 11 (10) Role of the neodymium YAG laser in the management of tracheal tumours thyroid (carcinoma) in two patients, and the kidney (clear cell adenocarcinoma) in one patient.
Indications for laser treatment On referral, 14 patients were in severe respiratory distress and were treated urgently with the laser; three of these patients had suffered episodes of apnoea before referral. The remaining seven were not severely breathless and were treated electively on the next routine list. George, Garrett, Hetzel Case history A 61 year old man gave a five year history of hoarseness of his voice, a feeling of fullness in the throat, and increasing breathlessness on exertion. Bronchoscopy showed an adenoid cystic carcinoma extending from immediately below the vocal cords to the lower third of the trachea. The lesion was considered to be inoperable and so he was referred for laser treatment. In one treatment the patency of the tracheal lumen was increased from about 40% to 80% of normal. This produced an immediate symptomatic improvement and flow-volume loops showed an appeciable improvement in inspiratory and expiratory flow rates (fig 2b) . He has since required two further treatments at intervals of three and four months.
Previous management

COMPLICATIONS OF LASER TREATMENT
One serious complication was seen in a patient with a secondary tumour. This patient became acutely 4 In the patients who were given radiotherapy laser treatment helped to protect the airway from the effects of radiation induced oedema. Thus the two patients who developed apnoeic episodes after starting radiotherapy were both able to complete their courses without further discomfort from dyspnoea. Although radiotherapy may produce a prolonged remission, many patients will relapse with locally recurrent disease.34 Most of these patients will be unsuitable for further radiotherapy and so laser treatment is an attractive option. In the present series seven patients were successfully managed by laser treatment alone after receiving maximum permissible doses of radiotherapy. We conclude that the laser led to a considerable improvement in the quality of life in these patients and helped to avoid a distressing death by asphyxiation.
The three patients who did not respond to laser treatment all had extensive extraluminal tumour causing appreciable extrinsic compression of the airway. One patient had already received maximum permissible doses of radiotherapy and was improved by a tracheal stent. ' George, Garrett, Hetzel As this series lacks a control group, we cannot determine precisely the contribution of laser treatment to survival. In the light of such dramatic responses, however, in patients with critical tracheal narrowing (see, for example, fig 2a) , it has been suggested that it would be unethical to perform a trial with a control group in which laser treatment was withheld. 4 This work was generously supported by Pilkington Medical Systems and the North East Thames Regional Health Authority. We are also indebted to Dr TN Mills and Sister A Ramu for their continuing technical support and to Dr MR Lewin for statistical advice. 
